ISSCR News
Plenary Speakers and Key Deadlines Announced for ISSCR 2025 Annual Meeting in Hong Kong
The International Society for Stem Cell Research (ISSCR) convenes world-renown scientists dedicated to stem cell research and regenerative medicine each year at its annual meeting to share the year’s most compelling basic discoveries and clinical breakthroughs in the stem cell field. Abstract submission and registration for ISSCR 2025, taking place 11-14 June 2025, will open on 2 October 2024. Abstracts submitted by 21 January 2025 will be considered for oral presentations and merit and travels awards.
New Podcast Episode. No Oligo Monopoly: Oligodendrocyte Precursor Cells in the Developing Cortex
Myelination is one of the last events during mammalian brain development and is thought to continue into young adulthood in humans. Even in adulthood, ongoing low-level myelination is essential for neural homeostasis, and for dynamic processes such as learning and memory. Deficits in myelination resulting in abnormal white matter and disruption of neuronal function are observed in a wide variety of disorders of the CNS. One strategy for alleviating these deficits is to enhance the genesis of myelin-forming oligodendrocytes from their upstream precursor parents, oligodendrocyte precursor cells (OPCs). However, the capability of these OPCs to contribute to remyelination in injury or disease in the adult CNS remains unclear. To better understand adult oligodendrogenesis and remyelination, our guests today characterized and compared murine OPCs during early postnatal myelination with those from adult injury-induced adult remyelination. Their findings identify two developing OPC groups subserving distinct postnatal functions and suggest that neonatal and adult OPC-mediated oligodendrogenesis are fundamentally different, The findings have important implications for therapeutic interventions aimed at myelin repair.
The ISSCR Reduces Publishing Fees in Stem Cell Reports by 50% for First-Time Members
The ISSCR is pleased to offer first-time Society members a 50% reduction in author publishing costs when publishing in Stem Cell Reports, the Society’s online, open access, peer-reviewed journal.
ISSCR Members Hold First Scientific Advice Meeting with the U.K.’s Medicines and Healthcare products Regulatory Agency
The International Society for Stem Cell Research (ISSCR) held its first Broader Scope Scientific Advice meeting with the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on May 15, 2023. ISSCR’s regulatory advocacy aims to give its members a voice to help educate policymakers about scientific findings and considerations that will help regulators make scientifically informed policy decisions and facilitate the development of advanced stem cell-based therapies and applications.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .